HBM Healthcare Investments AG (CH001262)

BRIEF

published on 05/22/2024 at 17:51, 6 months ago

HBM Healthcare Investments' Swixx BioPharma Expands in Latin America

HBM Healthcare Investments Latin America Expansion Biopharmaceutical Market Swixx BioPharma Biopas Acquisition
PRESS RELEASE

published on 05/22/2024 at 17:46, 6 months ago

HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
HBM Healthcare Investments' portfolio company Swixx BioPharma acquires Laboratorios Biopas Group in Latin America, boosting sales and profits. The strategic acquisition expands Swixx's footprint and market presence

Acquisition HBM Healthcare Investments Latin America Swixx BioPharma Biopas Group
BRIEF

published on 05/16/2024 at 17:52, 6 months 6 days ago

HBM Healthcare Investments AG Reports Recent Financial Performance

Financial Performance Asset Management HBM Healthcare Investments AG NAV Analysis Stock Price Trends
PRESS RELEASE

published on 05/16/2024 at 17:47, 6 months 6 days ago

Key Figures 15.05.2024
HBM Healthcare Investments AG reports key figures as of 15.05.2024, including performance percentages and total net assets in CHF. Contact details and disclaimer provided

Performance HBM Healthcare Investments AG Key Figures CHF Assets
BRIEF

published on 05/08/2024 at 18:42, 6 months 14 days ago

HBM Healthcare Investments Reports Balanced Financial Performance for 2023/2024

Portfolio Performance HBM Healthcare Investments Annual Financial Results Biotech Investments Currency Impact
PRESS RELEASE

published on 05/08/2024 at 18:37, 6 months 14 days ago

HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year
HBM Healthcare Investments almost broke even in the 2023/2024 financial year with a slight loss of CHF 1 million. Mixed portfolio performance with a 0.3% increase in NAV. Unfavourable currency developments affected results. Board proposes unchanged par value repayment of CHF 7.50 per share

Portfolio Performance HBM Healthcare Investments Financial Year 2023/2024 Currency Fluctuations Par Value Repayment
BRIEF

published on 05/01/2024 at 17:52, 6 months 21 days ago

HBM Healthcare Investments AG Reports April 2024 Financial Performance

Financial Performance HBM Healthcare Investments AG Share Price NAV April 2024
PRESS RELEASE

published on 05/01/2024 at 17:47, 6 months 21 days ago

Key Figures 30.04.2024
HBM Healthcare Investments AG reports key figures for April 30, 2024, with a NAV of 254.66 CHF and share price of 186.40 CHF, showing performance percentages. Total net assets stand at 1,745 million CHF

HBM Healthcare Investments AG Key Figures Share Price NAV April 30 2024
BRIEF

published on 04/16/2024 at 17:52, 7 months 6 days ago

HBM Healthcare Investments AG Reports Monthly Key Figures

Financial Performance HBM Healthcare Investments Share Price NAV Total Net Assets
PRESS RELEASE

published on 04/16/2024 at 17:47, 7 months 6 days ago

Key Figures 15.04.2024
HBM Healthcare Investments AG reports key performance figures for April 15, 2024. Net Asset Value (NAV) at 242.82 CHF and Share Price at 187.00 CHF. Total Net Assets reach 1,665 million CHF

Performance HBM Healthcare Investments AG Key Figures CHF April 15 2024

Published on 11/22/2024 at 23:55, 3 hours 52 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 4 hours 17 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 4 hours 42 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 4 hours 42 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 5 hours 17 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 9 hours 32 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 9 hours 47 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 9 hours 53 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 10 hours 51 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 11 hours 47 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 13 hours 12 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 20 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 8 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 10 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 10 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News